Memantine And Donepezil Capsule, Extended Release
Product Images NDC 33342-313

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Memantine And Donepezil (NDC 33342-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1111 (Memantine Donepezil Er 14 10mg 30s Bottle)

This is a description for a medication with NDC 33342-312-07, consisting of extended-release capsules containing 14 mg of memantine hydrochloride and 10 mg of donepezil hydrochloride. The usual dosage is one capsule taken once daily. It is recommended to store the medication in a tight, light-resistant container at temperatures between 20°C to 25°C. Manufactured by Macleods Pharmaceuticals Ltd in India for Macleods Pharma USA, Inc. located in Princeton, NJ 08540. Please refer to the package insert for complete prescribing information.*

FDA Label Image

2222 (Memantine Donepezil Er 14 10mg 90s Bottle)

This text provides information about a medication called Memantine and Donepezil Hydrochlorides Capsules, with each capsule containing 14 mg of memantine hydrochloride and 10 mg of donepezil hydrochloride. It suggests a usual dosage of taking one capsule daily. Storage instructions include keeping the capsules at a temperature of 20° to 25°C (68° to 77°F) in a light-resistant container. The medication is manufactured by Macleods Pharma USA, Inc. with a code number HP/152/07. Detailed prescribing information can be found in the package insert.*

FDA Label Image

3333 (Memantine Donepezil Er 14 mg 10 mg 100s)

This is a label for Maczoos Extended-release Capsules containing Memantine and Donepezil Hydrochlorides. The capsules are in a strength of 14 mg/10 mg and each package contains 100 single-dose capsules. The product is manufactured by Macleods Pharmaceuticals in India and distributed by Macleods Pharma USA, Inc. in Princeton, NJ. The usual dosage is one capsule daily. It is important to refer to the prescribing information for complete details before use.*

FDA Label Image

6666 (Memantine Donepezil Er 28 10mg 140s Carton)

FDA Label Image

4444 (Memantine Donepezil Er 28 10mg 30s Bottle)

This is a description of a medication labeled as NDC 33342-313-07, which is a combination of Memantine and Donepezil hydrochlorides in extended-release capsules with a strength of 28mg/10mg per capsule. The usual dosage is one capsule daily. The medication should be stored at 20° to 25°C and dispensed in a tight, light-resistant container. This medication is manufactured by Macleods Pharmaceuticals in Princeton, New Jersey, USA. For complete prescribing information, refer to the package insert.*

FDA Label Image

5555 (Memantine Donepezil Er 28 mg 10 mg 90s)

This text appears to be product information for a medication containing 28 mg of memantine hydrochloride extended-release and 10 mg of donepezil. The recommended dosage is one capsule daily. It is manufactured by Macleods Pharma USA, Inc. and should be stored at a temperature between 20° to 25°C. The medication should be dispensed in a tight, light-resistant container and kept out of the reach of children.*

FDA Label Image

Str (Memantine Donepezil Er Donepezil Structure)

FDA Label Image

Fig-1 (Memantine Donepezil Er Fig 1)

FDA Label Image

Fig-2 (Memantine Donepezil Er Fig 2)

FDA Label Image

Fig-3 (Memantine Donepezil Er Fig 3)

FDA Label Image

Fig-4 (Memantine Donepezil Er Fig 4)

FDA Label Image

Fig-5 (Memantine Donepezil Er Fig 5)

This text appears to be a brief report on a medical intervention or treatment evaluation, specifically mentioning the improvement over time, a change from the baseline, a particular dose of medication, and months of drug treatment. It may be related to a clinical study or patient progress monitoring in a healthcare setting.*

FDA Label Image

Fig-6 (Memantine Donepezil Er Fig 6)

FDA Label Image

Fig-7 (Memantine Donepezil Er Fig 7)

FDA Label Image

Fig-8 (Memantine Donepezil Er Fig 8)

FDA Label Image

Str (Memantine Donepezil Er Memantine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.